S M D Henley

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease
    Susie M D Henley
    Dementia Research Centre, Institute of Neurology, National Hospital for Neurology and Neurosurgery, University College London, Queen Square, London, United Kingdom
    Mov Disord 24:932-6. 2009
  2. ncbi Defective emotion recognition in early HD is neuropsychologically and anatomically generic
    Susie M D Henley
    Dementia Research Centre, Institute of Neurology, University College London, UK
    Neuropsychologia 46:2152-60. 2008
  3. ncbi Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease
    Susie M D Henley
    Dementia Research Centre, Institute of Neurology, University College, London, UK
    J Neurol 256:203-12. 2009
  4. ncbi Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study
    N Z Hobbs
    Dementia Research Centre and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, UK
    AJNR Am J Neuroradiol 31:1036-41. 2010
  5. ncbi Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease
    S M D Henley
    Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, United Kingdom
    AJNR Am J Neuroradiol 31:711-9. 2010
  6. ncbi Increased rate of whole-brain atrophy over 6 months in early Huntington disease
    S M D Henley
    Dementia Research Centre, Institute of Neurology, University College London, London, UK
    Neurology 67:694-6. 2006
  7. ncbi Biomarkers for neurodegenerative diseases
    Susie M D Henley
    Dementia Research Centre, Institute of Neurology, University College London, London, UK
    Curr Opin Neurol 18:698-705. 2005
  8. ncbi Extensive and temporally ungraded retrograde amnesia in encephalitis associated with antibodies to voltage-gated potassium channels
    Dennis Chan
    Department of Neurology, Royal Sussex County Hospital, Brighton, United Kingdom
    Arch Neurol 64:404-10. 2007
  9. ncbi Ten simple rules for reporting voxel-based morphometry studies
    Gerard R Ridgway
    Centre for Medical Image Computing, University College London, UK
    Neuroimage 40:1429-35. 2008

Detail Information

Publications9

  1. ncbi Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease
    Susie M D Henley
    Dementia Research Centre, Institute of Neurology, National Hospital for Neurology and Neurosurgery, University College London, Queen Square, London, United Kingdom
    Mov Disord 24:932-6. 2009
    ..Higher atrophy rates were associated with longer CAG repeat length. MRI-based measures of whole-brain atrophy may have potential as a measure of progression in HD...
  2. ncbi Defective emotion recognition in early HD is neuropsychologically and anatomically generic
    Susie M D Henley
    Dementia Research Centre, Institute of Neurology, University College London, UK
    Neuropsychologia 46:2152-60. 2008
    ..Even in early HD there is a wide-ranging impairment in recognition of negative emotions denoting 'threat'. Our findings implicate a generic fronto-subcortical network in the pathogenesis of these emotion recognition deficits...
  3. ncbi Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease
    Susie M D Henley
    Dementia Research Centre, Institute of Neurology, University College, London, UK
    J Neurol 256:203-12. 2009
    ..Overall we have demonstrated that increased CAG repeat length is associated with atrophy in extra-striatal as well as striatal regions, which has implications for the monitoring of disease-modifying therapies in the condition...
  4. ncbi Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study
    N Z Hobbs
    Dementia Research Centre and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, UK
    AJNR Am J Neuroradiol 31:1036-41. 2010
    ..This may prove useful in assessing disease-modifying treatments. We investigated how caudate and global volumes change as HD progresses from premanifest to early disease...
  5. ncbi Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease
    S M D Henley
    Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, United Kingdom
    AJNR Am J Neuroradiol 31:711-9. 2010
    ....
  6. ncbi Increased rate of whole-brain atrophy over 6 months in early Huntington disease
    S M D Henley
    Dementia Research Centre, Institute of Neurology, University College London, London, UK
    Neurology 67:694-6. 2006
    ..10 [0.88]%/year; controls, 0.26 [0.54]%/year). The measurement of cerebral change over short time periods (e.g., 6 months) may be relevant for trials designed to assess effects on neurodegeneration or atrophy...
  7. ncbi Biomarkers for neurodegenerative diseases
    Susie M D Henley
    Dementia Research Centre, Institute of Neurology, University College London, London, UK
    Curr Opin Neurol 18:698-705. 2005
    ..This review summarizes the field of biomarker research in the major neurodegenerative diseases...
  8. ncbi Extensive and temporally ungraded retrograde amnesia in encephalitis associated with antibodies to voltage-gated potassium channels
    Dennis Chan
    Department of Neurology, Royal Sussex County Hospital, Brighton, United Kingdom
    Arch Neurol 64:404-10. 2007
    ..Magnetic resonance imaging reveals abnormal signal predominantly restricted to the mediotemporal lobes...
  9. ncbi Ten simple rules for reporting voxel-based morphometry studies
    Gerard R Ridgway
    Centre for Medical Image Computing, University College London, UK
    Neuroimage 40:1429-35. 2008
    ..This editorial suggests core principles that should be followed and information that should be included when reporting a VBM study in order to make it transparent, replicable and useful...